Cardio Diagnostics Holdings, Inc.
CDIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 104.5% | 1,696.3% | 5.4% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $8 | $7 | $4 | $0 |
| SG&A Expenses | $8 | $7 | $4 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $8 | $7 | $5 | $1 |
| Operating Income | -$8 | -$7 | -$5 | -$1 |
| % Margin | -23,977.9% | -42,440.4% | -478,784.3% | -68,862.2% |
| Other Income/Exp. Net | -$0 | -$1 | -$0 | $0 |
| Pre-Tax Income | -$8 | -$8 | -$5 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$8 | -$8 | -$5 | -$1 |
| % Margin | -24,028.2% | -49,087.8% | -490,630% | -68,862.2% |
| EPS | -9.3 | -19.8 | -45.3 | -1.96 |
| % Growth | 53% | 56.3% | -2,211.2% | – |
| EPS Diluted | -9.3 | -19.8 | -45.3 | -1.96 |
| Weighted Avg Shares Out | 27 | 0 | 3 | 0 |
| Weighted Avg Shares Out Dil | 27 | 0 | 3 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $7 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$8 | -$2 | -$5 | -$1 |
| % Margin | -23,182.8% | -8,966.9% | -488,945.8% | -67,086.3% |